| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.02▲ | 6.04▲ | 6.04▲ | 5.98▼ | 5.08▲ |
| MA10 | 6.08▲ | 6.20▼ | 6.20▼ | 6.10▼ | 3.09▲ |
| MA20 | 6.26▼ | 6.25▼ | 6.27▼ | 5.38▲ | 2.56▲ |
| MA50 | 5.37▲ | 4.38▲ | 3.83▲ | 2.92▲ | 11.71▼ |
| MA100 | 3.10▲ | 2.67▲ | 2.56▲ | 2.58▲ | 222.92▼ |
| MA200 | 2.19▲ | 2.21▲ | 2.15▲ | 6.79▼ | 3,793.89▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.122▼ | -0.194▼ | -0.224▼ | -0.124▼ | 4.580▲ |
| RSI | 56.279▲ | 61.164▲ | 65.125▲ | 69.632▲ | 34.927▼ |
| STOCH | 27.737 | 14.343▼ | 14.343▼ | 11.584▼ | 56.890 |
| WILL %R | -67.925 | -67.925 | -67.925 | -91.732▼ | -18.479▲ |
| CCI | -33.771 | -57.297 | -52.827 | -78.065 | 110.277▲ |
|
Tuesday, October 27, 2026 03:06 AM
Medical tech company CONMED (NYSE:CNMD) will be reporting earnings this Wednesday after the bell. Here’s what you need to know.
|
|
Tuesday, October 27, 2026 01:22 AM
Milestone advances Clearmind’s clinical program as the company continues to develop CMND‑100 as a potential novel therapeutic candidate for ...
|
|
Friday, September 11, 2026 03:00 AM
Vancouver, Canada, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (the “Company”), a clinical-stage biopharmaceutical company advancing non-hallucinogenic ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/10/26 | 6.095 | 6.095 | 5.9476 | 5.9673 | 5,366 |
| 26/10/26 | 5.92 | 6.20 | 5.8598 | 6.1214 | 16,249 |
| 23/10/26 | 6.255 | 6.255 | 5.87 | 5.87 | 8,400 |
| 22/10/26 | 6.01 | 6.095 | 6.00 | 6.00 | 5,300 |
| 21/10/26 | 6.253 | 6.253 | 5.92 | 5.94 | 5,200 |
| 20/10/26 | 5.9706 | 6.19 | 5.91 | 6.12 | 6,971 |
| 19/10/26 | 6.1638 | 6.362 | 5.91 | 6.00 | 8,271 |
| 16/10/26 | 6.33 | 6.47 | 6.2601 | 6.2601 | 3,789 |
| 15/10/26 | 6.24 | 6.79 | 6.24 | 6.42 | 5,565 |
| 14/10/26 | 6.36 | 6.47 | 6.20 | 6.2889 | 10,628 |
|
|
||||
|
|
||||
|
|